KMC Speciality Hospitals (India)
- Market cap
- ₹ 2,350 Cr.
- P/E
- 44.1x
- P/B
- 11.74x
- 52-week range
- 128.48 – 185.5
- ROE
- 25%
- ROCE
- 26%
- Dividend yield
- 0%
- Debt / equity
- 0.4
- Sector
- Healthcare Services
- Industry
- Hospital
- Listed on
- NSE, BSE
About
KMC Speciality Hospitals (India) Limited is an India-based company, which is engaged in the business of rendering medical and healthcare services. The Company operates through Medical and Healthcare Services segment. It provides various services, such as anesthesiology, cardiology, critical care, dermatology, dental maxillofacial, ophthalmology, endocrinology, general surgery, ENT, head and neck surgery, laboratory services, obstetrics and gynecology, IVF and infertility, psychiatry, pulmonology, rheumatology, lung center, general medicine, diabetology, orthopedics, oncology, spine surgery, neurology, liver disease, gastroenterology, geriatrics, nephrology and urology science, vascular surgery, pediatrics and neonatology, infectious diseases, plastic surgery, breast clinic, maa kauvery-comprehensive mother and childcare. It provides various services through its centers, such as cardiac science, neurology, general medicine, diabetology, spine surgery, orthopedics, geriatrics, and more.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Hospital: 41 companies →KMC Speciality Hospitals (India) against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)44.1 against a typical 48.9: cheaper than most peers (1st = cheapest).18th of 40
- Sales growth+37.3% against a typical +21.1% from a year earlier.8th of 34
- Profit growth+112.5% against a typical +13% from a year earlier.3rd of 31
- Size₹ 2,350.1 Cr. market value against a typical ₹ 1,306.7 Cr. (1st = largest).17th of 36
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
High safety
Rated AA- by India Ratings- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| India Ratings | IND AA-; IND A1+ | Stable | 12 Jun 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 12 Jun 2026 | Reaffirmed | IND AA- | — | India Ratings | ₹ 77.81 Cr. | |
| 18 Mar 2026 | Rating action | IND AA- | — | India Ratings | ₹ 77.81 Cr. |
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 42 | 49 | 45 | 53 | 56 | 61 | 61 | 67 | 75 | 82 | 82 | 92 |
| Expenses | 31 | 35 | 33 | 40 | 44 | 45 | 46 | 50 | 54 | 57 | 56 | 63 |
| Operating Profit | 11 | 14 | 12 | 13 | 13 | 16 | 15 | 16 | 21 | 25 | 26 | 28 |
| OPM % | 26% | 29% | 26% | 24% | 22% | 26% | 25% | 25% | 28% | 30% | 31% | 31% |
| Other Income | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Interest | 0 | 0 | 0 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 2 | 2 | 3 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 |
| Profit before tax | 9 | 12 | 9 | 7 | 5 | 10 | 9 | 10 | 15 | 18 | 20 | 22 |
| Tax % | 26% | 24% | 25% | 26% | 27% | 25% | 49% | 25% | 26% | 26% | 26% | 26% |
| Net Profit | 7 | 9 | 7 | 6 | 4 | 8 | 5 | 8 | 11 | 14 | 15 | 17 |
| EPS in Rs | 0.42 | 0.58 | 0.43 | 0.34 | 0.24 | 0.46 | 0.28 | 0.46 | 0.66 | 0.84 | 0.9 | 1.02 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 22%
- 5 Years
- 24%
- 3 Years
- 25%
- TTM
- 35%
- 10 Years
- 31%
- 5 Years
- 30%
- 3 Years
- 20%
- TTM
- 138%
- 10 Years
- 33%
- 5 Years
- 22%
- 3 Years
- 23%
- TTM
- —
- 10 Years
- 23%
- 5 Years
- 23%
- 3 Years
- 21%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| KMC Speciality Hospitals (India) | ₹ 150.40 | ₹ 2,350 Cr. | 44.1x | 11.7x | 25% | — |
| Delhivery | ₹ 370.00 | ₹ 27,724 Cr. | 226x | 3.8x | 1.6% | 1.5% |
| Urban Company | ₹ 132.65 | ₹ 20,457 Cr. | — | 8.9x | −11.9% | −15.1% |
| Indegene | ₹ 570.00 | ₹ 13,763 Cr. | 29.5x | 3.9x | 13.9% | 11.4% |
| BLS International Services | ₹ 208.70 | ₹ 8,593 Cr. | 14.2x | 3.9x | 32.7% | 24.1% |
| Axiscades Technologies | ₹ 1,915.00 | ₹ 8,154 Cr. | 83.3x | 9.1x | 10.5% | 6.2% |
Management
- Sundararaj Chandrakumar
- Whole-Time Chairman of the Board
- Kumarswamy Anand Babu
- Chief Financial Officer
- Indumathi P.
- Company Secretary and Compliance Officer
- Selvaraj Manivannan
- Managing Director, Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.